Introduction Rotavirus vaccine was introduced in Mauritania in December 2014. We
investigated hospitalizations with diarrhea during pre and post-vaccination periods among …

Background In 2006, Brazil began routine immunization of infants< 15 wk of age with a
single-strain rotavirus vaccine. We evaluated whether the rotavirus vaccination program was …

Background WHO recommends routine use of rotavirus vaccines in all countries, particularly
in those with high mortality attributable to diarrhoeal diseases. To establish the burden of life …

Background Rotavirus is a leading cause of mortality among children< 5 years old. We
evaluated monovalent rotavirus vaccine effectiveness (VE) under conditions of routine use …

Background Monovalent rotavirus vaccine (RV1) was introduced in Lusaka in February
2012 and rolled out countrywide in November 2013 in the routine Expanded Programme on …

Background Monovalent rotavirus vaccine substantially reduced rotavirus disease burden
after introduction (May 2014) in Madagascar. We examined the effectiveness and long-term …

Background. A monovalent human rotavirus vaccine (RV1) was introduced in Botswana in
July 2012. We assessed the impact of RV1 vaccination on childhood gastroenteritis-related …

Background: A recent postlicensure study from El Salvador showed that the monovalent
rotavirus vaccine conferred 76% protection against rotavirus hospitalizations. We further …

Background Rotavirus vaccine use in national immunisation programmes has led to
declines in hospital admissions for rotavirus gastroenteritis among children; however, the …

ABSTRACT Background: Of the 215,000 global deaths from rotavirus estimated in 2013,
41% occur in Asian countries. However, despite a recommendation for global rotavirus …